The German pharmaceutical-and-agricultural group stated that the deal goals to enhance its ophthalmology pipeline.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Related Posts
Opinion | Tyler Robinson and America’s Lost Boys
What causes a younger man to spiral from success towards loneliness, self-destruction and violence? Source link
Meta’s $2B Manus deal pushes away some customers sad it happened
When Meta agreed to spend a reported $2 billion on Manus on the finish of final 12 months, the social…
Japan Airlines to trial robots at Tokyo’s Haneda airport to load baggage
LOS ANGELES, CALIFORNIA – MARCH 7: A Japan Airways Boeing 787 Dreamliner departs Los Angeles Worldwide Airport en path to…